To include your compound in the COVID-19 Resource Center, submit it here.

Lilly returns hGH rights to Emisphere

Eli Lilly (LLY) returned all rights to an oral recombinant

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE